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Abstract
The current opioid epidemic substantially affects African Americans given their 
historical rate of disparities in access to effective substance use disorder (SUD) 
treatment. Yet, there is limited information about factors that may improve access 
to effective opioid use disorder (OUD) treatment for members of this racial group. 
This chapter describes policy, management, and treatment practices that may 
enhance access and engagement of African Americans in OUD treatment consider-
ing the current opioid epidemic and the state of public treatment systems in the 
United States. Drawing from a sociocultural framework on disparities in access 
to care, I present a comprehensive approach based on culturally competent and 
medication-assisted treatment that may reduce the wait time to enter treatment 
and increase treatment engagement and recovery rates among African Americans 
seeking OUD treatment. I focus on the role of public insurance (i.e., Medicaid), the 
diversification of the workforce, as well as delivery of adequate dosages of mainte-
nance opioid medications (methadone, buprenorphine, and naltrexone) to improve 
engagement and recovery. Implications for health policy, program design, and 
service delivery are discussed to abate the effect of the opioid epidemic on African 
American communities.
Keywords: African Americans, opioid use disorder treatment, Medicaid,  
cultural competence, treatment effectiveness
1. Introduction
African American communities are disproportionally affected by the opioid 
epidemic. The CDC estimates that from 2014 to 2016 opioid overdose deaths 
increased by 45.8% for whites but 83.9% for African Americans [1]. Although white 
and rural communities have reported alarming overdose rates, African American 
communities in urban and suburban communities have seen a steady growth of 
overdoses over a longer period. In particular, the opioid epidemic has dispropor-
tionately affected African-American communities, who are most likely than whites 
to be uninsured or underinsured and unable to enter and stay in opioid use disorder 
(OUD) treatment.
It is well established that African Americans are more likely than whites to 
experience difficulty entering and staying in outpatient SUD treatment [2–6]. 
Researchers have examined wait time to enter treatment and retention in treatment 
to develop strategies to improve treatment engagement and improve the likelihood 
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of maintaining clients in recovery from opioid use. Wait time to treatment entry is 
the most commonly cited barrier, and most studies show that African American cli-
ents wait more days to enter SUD treatment than non-Hispanic white clients [6–8]. 
Treatment retention, or time spent in treatment, is a robust predictor of reduced 
post-treatment substance use [9]. National studies show that treatment programs 
that provide care to minority populations used fewer approaches to maintain client 
retention [10–13]. In addition, the importance of insurance coverage to enhance 
access to OUD treatment for African Americans is noted.
However, since the implementation of the Affordable Care Act, the percentage 
of clients without insurance in predominately African-American opioid treatment 
programs (OTPs) dropped from 45% in 2014 to 20% in 2017, which is promising 
[14, 15]. Delivering culturally responsive care is also critical to engaging African 
Americans in OUD treatment and reducing the negative effects of the opioid 
epidemic. In particular, investing in a diverse workforce that is qualified to respond 
to the technical aspects of medication-assisted treatment and the cultural services 
needs of African-Americans is critical [16, 17].
The information in this chapter can help policy makers and program managers 
to make informed decisions about how to allocate scarce resources to help African 
Americans access effective OUD treatment. Although there are a variety of prac-
tices to support treatment access, engagement, and recovery, this chapter focuses 
on robust approaches to help African Americans considering the current healthcare 
environment. In this chapter, I describe the evidence supporting Medicaid coverage 
and delivery of cultural competence in OUD treatment.
2.  Cultural competence to enhance access and engagement in OUD 
treatment for African Americans
Cultural competency is theoretically justified, and mounting evidence supports 
some of the multiple components or practices to improve engagement and OUD treat-
ment outcomes [18]. However, standardized and empirically validated comprehensive 
scales through which to measure organizational cultural competence have been lacking 
[19]. Yet, workforce diversity, which allows matching clients and providers based on 
language and cultural background and ensuring connections with minority communi-
ties have received empirical support [7, 20]. These measures of workforce diversity 
based on matching have been associated with higher treatment access and retention. 
A meta-analysis also showed a small, but significant treatment effect of culturally 
adapted interventions on substance use behaviors among African Americans and 
Hispanics [21]. This previous research shows promise but requires policy and program 
investment in tailoring services to the needs of African Americans.
Workforce diversity has become an effective practice to address healthcare dispari-
ties in treatment outcomes [22–24]. Following Brach and Fraser, I define workforce 
diversity as the demographic and cultural representation of health workers and man-
agers that reflect inclusion of backgrounds that are representative of the client popu-
lation [25]. A diverse workforce is one of the main practices of cultural competence, 
which is defined as a set of behaviors, attitudes, and policies that enable a system, 
organization, or individual to function effectively with culturally diverse clients and 
communities [18]. I draw from the culturally and linguistically appropriate services 
(CLAS) denomination used by federal health agencies [26–28], which has six main 
components, Leadership, Quality Improvement and Data Use, Workforce, Patient 
Safety and Provision of Care, Language Services, and Community Engagement. For 
a complete list of CLAS practices, please refer to the US Department of Health and 
Human Services (DHHS), Office of Minority Health. This comprehensive approach 
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describes a healthcare system responsive to the cultural and linguistic service needs of 
members of racial and ethnic minority individuals.
Workforce diversity as a key practice in CLAS may help OTPs engage African-
Americans who are most likely to drop out of treatment. Previous cross-sectional 
analyses of national representative databases show that SUD treatment programs 
that cater to minority populations experience decreased retention in treatment or 
employed methods to maintain retention [9–11, 29, 30]. In contrast, SUD treatment 
programs with African American supervisors [16] predicted highest degrees of 
cultural competence. As culturally competent practices can encompass a wide array 
of organizational arrangements, practices, and services, it is critical for program 
administrators and counselors to determine which components of CLAS are needed 
to engage African Americans in OUD treatment.
The importance of diversifying the workforce and delivering CLAS in the SUD 
treatment system stems from disparate research suggesting that the discordance 
between the racial background of clients and treatment staff may contribute to health 
and healthcare disparities [16, 31–34]. Congruence between the cultural and the 
linguistic backgrounds of staff and clients is thought to elevate the competencies of 
healthcare providers and improve client treatment adherence via the use of racial/ethnic 
history and cultural norms, as well as the reliance on client’s native language [16, 35–37]. 
Furthermore, having a diverse workforce may create a conducive climate for imple-
menting CLAS [38, 39] and addressing treatment outcome disparities among minorities 
[16, 40–42]. The field has seen an increased diversity among SUD clients, but it is not 
clear how reliably provider/client matching yields positive results [16, 17, 43–45].
Federal, state, and professional organizations have promoted cultural competence 
to improve SUD treatment engagement (see DHHS Office of Minority Health). 
Federal regulation, through Medicaid payments of healthcare service has strengthen 
the focus on delivering services that respond to the cultural and linguistic services 
needs of clients (DHHS, Medicaid). The National Institute of Medicine, National 
Institute of Nursing, and the National Association of Social Workers have promoted 
workforce diversity strategies, as well as developed training standards for cultural 
competency [46–50]. Regulation at the federal, state, and professional certification 
levels has incorporated cultural competence in healthcare services [51–54]. More 
directly to the proposed research, the Substance Abuse and Mental Health Services 
Administration called providers to rely on CLAS because the majority of SUD coun-
selors are non-Hispanic whites even as almost half who seek treatment are non-white.
Prior research shows that the minority background of managers and counselors 
is associated with higher rates of treatment access and retention among Latino and 
African American clients [55–57]. The use of the proposed conceptual framework 
may expand understanding of drivers of workforce diversity and treatment outcomes. 
To improve the quality of care provided to African American communities, it is criti-
cal to ensure that the different stakeholders understand the service needs of African 
Americans. This includes engaging policy makers, healthcare administrators, pro-
gram directors, as well as treatment providers, clients, and people living in the service 
area who are not clients of the healthcare organization. This comprehensive approach 
to improve the cultural competency of OUD treatment can have a significant impact 
on access, retention, and recovery rates of African Americans struggling with OUDs.
3.  Medication-assisted treatment and ensuring adequate dosages  
of opioid maintenance medication
Medication-assisted treatment (MAT) is a pharmacological intervention that 
relies on specific drugs (e.g., methadone, buprenorphine, or naloxone) to reduce 
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the cravings or block the effects of opioid use. Unfortunately, only one-third of 
SUD treatment programs offer MAT in the United States, while those opioid treat-
ment programs (OTPs) who provide these medications may not deliver them in 
adequate dosages compromising the recovery of clients.
Methadone is the most common opioid maintenance medication in the United 
States. It is used as a replacement for illicit opioid use, such as heroin, in medically 
supported opioid substitution maintenance programs, referred here as OTPs [58]. 
Buprenorphine, introduced after methadone, has received significant support to 
reduce illicit opioid use but has not been widely implemented in OTPs. The effects of 
buprenorphine may last longer than methadone as it can be taken once every 2 days.
The issue of OTPs providing adequate dosage has been an increasing concern 
considering the high regulation of medication-assisted programs and the impact 
on the client population. Emerging research suggests that Methadone doses higher 
than 60 mg/day are associated with significant declines in heroin consumption [58] 
and other drug use, as well as with longer retention in treatment and lower rates of 
relapse [59–63].
However, 41% of patients received lower doses [64] with African Americans 
more likely to receive doses less than 40 mg/day [17]. This initial findings are 
concerning as African American communities are disproportionally affected by the 
opioid epidemic and face significant barriers to access OUD treatment.
Significant evidence shows that buprenorphine at high doses (15 mg) can reduce 
illicit opioid use effectively [65]. There is limited evidence of African Americans 
receiving inadequate dosages of buprenorphine, but research has showed that 
African American communities have less access to buprenorphine treatment 
compared with White communities.
Adequate dosage of naltrexone is suggested at 50 mg/day [65, 66], but similar 
to buprenorphine, evidence is limited regarding the adequate dosage of naltrexone 
in African American communities, while there is some evidence that these com-
munities have less access to naltrexone compared to white communities. Enhancing 
African American communities’ access to MAT and ensuring that maintenance 
dosages are adequate to maintain recovery should be a primary goal of public health 
leaders to abate the opioid epidemic.
4. Conceptual framework
The sociocultural framework of substance abuse service disparities [67] suggests 
that racial disparities in treatment service use originates when healthcare system 
factors, such as policy, community, and providers differently respond to individuals 
partly based on their racial/ethnic background. For instance, different stratified 
conditions emerge when healthcare markets fail in minority communities creating 
different pathways to access treatment. At the provider level, poor patient-provider 
communication, lack of trust, and poor workforce availability or competency 
further differentiates services to minority from services to white clients. As a result 
of these differences in service provision, racial minorities face greater risk than 
non-Hispanic whites of dropping out of care and receiving lower quality of care, 
resulting in worse treatment outcomes [68]. Growing evidence in differences in 
implementation of health policy in minority communities, provider discrimination, 
and provider resources offer support for this framework.
I also draw from a diversity and inclusion and funding and regulatory frame-
works to describe how racial disparities in OTP may emerge and how to eliminate 
them. The diversity and inclusion framework proposes that by increasing racial 
diversity of the OTP workforce, OTPs will be able to be respond to the barriers to 
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access and engagement in treatment [69]. Developing a diverse workforce may 
enhance OTPs’ capacity to deliver CLAS, but OTP’s organizational and client factors 
may determine when OTPs workforce diversity and delivery of culturally respon-
sive care have an impact on process outcomes.
Opioid treatment programs (OTPs) rely heavily on their regulatory and funding 
environment for financial and nonfinancial (i.e., professional expertise) resources, 
making them vulnerable to funding and regulatory expectations [7, 70]. OTPs also 
rely on having a high staff to client ratio to respond to client service needs. The 
racial/ethnic diversity of the client population is also critical for OTPs to invest 
in cultural competency and improving process outcomes [16]. These dynam-
ics are consistent with resource-dependence theory [71], which posits that high 
dependence on necessary resources (Medicaid funding, staffing, and diverse base) 
determines an organization’s practices (e.g., workforce diversity) and selection of 
core service technologies (e.g., CLAS).
By accepting Medicaid funding, OTPs increase their revenue, but also are 
pressured to comply with government-endorsed culturally responsive care [72, 73]. 
Because accepting Medicaid payments may be a proxy for institutional pressures 
to deliver CLAS and enhance access to healthcare, Medicaid acceptance and the 
delivery of CLAS may potentially reduce disparities in process outcomes among 
OTPs primarily serving African Americans and Hispanics. Delivering CLAS may 
improve OUD treatment programs access, increase retention, and increase percent 
of clients receiving adequate MAT maintenance dosage when OTPS accept Medicaid 
payments and when staff/client ratios are high.
Providing African Americans with adequate dosages of methadone, buprenor-
phine, and or naltrexone is likely to support their commitment to maintenance 
medication and improve their recovery efforts. A consistent and adequate dosage of 
these maintenance medications is associated with positive psychosocial, emotional, 
and labor outcomes. Hence, it is critical to develop the health policies, insurance 
coverage, service practices, and workforce competencies to deliver culturally 
responsive and adequate dosing of opioid maintenance medication.
4.1 Organizational factors improving cultural competence and recovery
Prior research on cultural competence in SUD treatment using national data has 
found that SUD treatment organizations with the highest degree of cultural com-
petence have clinical supervisors and staff who are African American [16]. Studies 
also show that SUD treatment, when provided using different CLAS, is associated 
with reduced racial disparities in client access and engagement [7]. For instance, 
in one of the largest studies on cultural competence, Dr. Guerrero and colleagues 
included measures from more than 110 treatment organizations and clinical records 
from 28,000 clients from minority backgrounds. Using these data, they showed that 
culturally responsive practices are significantly related to client access to treatment 
services, retention in treatment, and treatment completion [74]. The comprehensive 
set of organizational practices, (culturally responsive policies and practices, outreach 
to minority communities, workforce diversity, involvement in minority communi-
ties, etc.) make a differences in enhancing treatment access and engagement, as well 
as ensuring clients meet their treatment plan goals to be successfully discharged.
A critical aspect of OUD treatment is medication dosage. Growing evidence 
suggests that OTP client characteristics and organizational factors are associated 
with methadone dose levels [73, 75]. Characteristics of patient mix (percentage of 
African American patients), employment status (percentage of patients who are 
currently unemployed), and patient age (percentage of patients aged 40 or above) 
are associated with dosage levels above 60 mg/day. Program factors associated with 
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methadone dose levels below 60 mgs/day also include program ownership (public, 
private for profit, and private not-for-profit) accreditation by either the Joint 
Commission (TJC) or the Commission on Accreditation of Rehabilitation Facilities 
(CARF), the percentage of staff members who are ex-addicts [75] and African 
American director, particularly in programs serving populations with higher 
percentages of African American patients [17, 64, 76]. It is critical to understand the 
extent to which CLAS may improve OTPs’ likelihood of providing adequate MAT 
dosages in programs serving African American and Latino clients.
Altogether, organizational factors play an important role in the delivery of 
quality of care for African Americans. When treatment programs provide culturally 
responsive care, clients engage and respond to treatment. This means that if OTP 
services are delivered by African American staff with competencies to understand 
and address the cultural, linguistic, and social service needs of African American 
clients, these clients are likely to enter, stay, and benefit from OUD treatment.
5. Conclusions
African Americans seeking to enter SUD treatment face significant challenges to 
engage, stay, and benefit from treatment. Increasing evidence suggests that cultur-
ally responsive practices that include workforce diversity as well as policies, prac-
tices and services that are responsive to the service needs of African Americans may 
improve the effectiveness of SUD treatment. African American clients struggling 
with OUDs may benefit from MAT, in particular three of the most effective medica-
tions to address OUD, methadone, buprenorphine, and naltrexone, but ensuring 
that OTPs deliver MAT, adequate dosages to help African American clients achieve 
medication maintenance and recovery is critical.
The socio-technical and cultural framework offered in this chapter highlights 
several factors that may improve treatment of OUD among African Americans. 
The health policy like Medicaid expansion coverage will ensure effective access to 
treatment by ensuring ability to pay. This funding also regulates the quality of care, 
including provision of culturally responsive practices, which include having staff 
that represent the racial background of clients. The assumption is that the provide-
client matching will elevate the cultural understanding of client’s OUD issues and 
address them effectively. The provision of MAT is critical to address OUD, but 
ensuring adequate dosage of the right type of maintenance medication is necessary. 
Healthcare system administrators, program managers, and addiction counselors 
should ensure that African Americans have effective access to the right medication 
at adequate dosages, and that outcome reporting is available.
5.1 Implications for OUD treatment for African Americans
Opioid use disorder treatment for African Americans may become 
more effective when investing in program design, a diverse workforce, and 
MAT. Because research has showed that culturally competent units are typically 
public, federal-funded organizations and with highly trained staff, in terms 
of college-educated and professionally certified, it is critical to rely on public 
funding (Medicaid), professional accreditation standards, and build on staff 
competencies to deliver OUD treatment that is effective. Culturally competent 
programs also have a high percent of clients with high severity of illness and 
social issues [16]. To increase the effectiveness of OUD treatment for an African 
American population that struggles with other health-related issues, it is critical 
to integrate MAT and medical services.
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Because SUD treatment programs that invest in cultural competence are more likely 
to invest in ancillary servicessuch as employment counseling, spiritual strength, and 
physical health, it is also critical for Medicaid reimbursement policies, insurance cover-
ages, program management, and services delivery to respond to the multiple service 
needs that compromise the recovery of African Americans from opioid use [16, 17].
Policy makers, healthcare administrators, program managers, and counselors 
need to work conjointly to use their unique knowledge to tailor policies, adjust 
budgets, design healthcare coverage, and services and prepare the workforce to 
response to the services needs of African Americans. To reduce the impact of the 
opioid epidemic on African American communities, public health systems need to 
improve access to culturally responsive and evidence-based care including effective 
MAT. Tailoring policies and services to the needs of the racial minority group most 
represented in OUD treatment has benefit to all members of society.
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